While UGP2 is widely recognized for its role in catalyzing the production of UDP-glucose for glycogen synthesis in normal physiology [5,6], our data strongly suggest a context-dependent, non-canonical tumor-suppressive role specifically within the tissue microenvironment of CRC. The gene discussed is UGP2; the disease is neoplasm.